US Patent Issued to Omeros on July 8 for "Methods of inhibiting MASP-2 for the treatment and/or prevention of coronavirus-induced acute respiratory distress syndrome" (Washington Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,648, issued on July 8, was assigned to Omeros Corp. (Seattle).

"Methods of inhibiting MASP-2 for the treatment and/or prevention of coronavirus-induced acute respiratory distress syndrome" was invented by Gregory A. Demopulos (Seattle) and Tineka J. Quinton (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "In one aspect, the invention provides methods for treating, inhibiting, alleviating, or preventing acute respiratory distress syndrome, pneumonia, or some other pulmonary or other manifestation of coronavirus infection, such as thrombosis, in a mammalian subject infected with coronavirus, such as SARS-CoV-2. The methods comprise the step of a...